The heparan sulfate-specific epitope 10E4 is NO-sensitive and partly inaccessible in glypican-1

Glycobiology

Volumn 14, Issue 7, 2004, Pages 599-607

  Mani, Katrin ^b   Cheng, Fang ^b   Sandgren, Staffan ^b   van den Born, Jacob ^c   Havsmark, Birgitta ^b   Ding, Kan ^a   Fransson, Lars Åke ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LUND UNIVERSITY   (Sweden)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Glypican 1; Heparan sulfate; Heparanase; mAb 10E4; Nitric oxide

Indexed keywords

ASCORBIC ACID; EPITOPE; GLUCOSAMINE; GLYPICAN; HEPARAN SULFATE; HEPARANASE; HEPARIN LYASE; MANNOSE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 10E4; NITRIC OXIDE; PROTEOGLYCAN; SURAMIN; UNCLASSIFIED DRUG;

ANTIBODY ISOLATION; ANTIBODY SPECIFICITY; ANTIGEN RECOGNITION; ARTICLE; CELL PH; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DEAMINATION; DEGRADATION; ENDOSOME; ENZYME INHIBITION; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IN VIVO STUDY; ISOLATION PROCEDURE; ISOTOPE LABELING; NITROSYLATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; ENDOSOMES; EPITOPES; GLUCOSAMINE; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OLIGOSACCHARIDES; RECOMBINANT PROTEINS; SURAMIN;

EID: 3142664810     PISSN: 09596658     EISSN: None     Source Type: Journal    
DOI: 10.1093/glycob/cwh067     Document Type: Article

References (27)

1. Arroyo-Yanguas, Y., Cheng, F., Isaksson, A., Fransson, L.-Å., Malmström, A., and Westergren-Thorsson, G. (1997) Binding, internalization and degradation of antiproliferative heparan sulfate by human embryonic lung fibroblasts. J. Cell. Biochem, 64, 595-604.
2. Belting, M., Persson, S., and Fransson, L.-Å. (1999) Proteoglycan involvement in polyamine uptake. Biochem. J., 338, 317-323.
3. Belting, M., Mani, K., Jönsson, M., Cheng, F., Sandgren, S., Jonsson, S., Ding, K., Delcros, J.-G., and Fransson, L.-Å. (2003) Glypican-1 is a vehicle for polyamine uptake in mammalian cells. A pivotal role for nitrosothiol-derived nitric oxide. J. Biol. Chem., 278, 47181-47189.
4. Brown, D.R. (2002) Copper and prion diseases. Biochem. Soc. Trans., 30, 742-745.
5. Cheng, F., Mani, K., van den Born, J., Ding, K., Belting, M., and Fransson, L.-Å. (2002) Nitric oxide-dependent processing of heparan sulfate in recycling S-nitrosylated glypican-1 takes place in caveolin-1-containing endosomes. J. Biol. Chem., 277, 44431-44439.
6. David, G., Bai, X.M., Van der Schueren, B., Cassiman, J.-J. and Van den Berghe, H. (1992) Developmental changes in heparan sulfate expression: in situ detection with mAbs. J. Cell Biol., 119, 961-975.
7. Ding, K., Jönsson, M., Mani, K., Sandgren, S., Belting, M., and Fransson, L.-Å. (2001a) N-unsubstituted glucosamine in heparan sulfate of recycling glypican-1 from suramin-treated and nitrite-deprived endothelial cells. Mapping of the nitric oxide/nitrite-susceptible glucosamine residues to clustered sites near the core protein. J. Biol. Chem., 276, 3885-3894.
8. Ding, K., Sandgren, S., Mani, K., Belting, M., and Fransson, L.-Å. (2001b) Modulations of glypican-1 heparan sulfate structure by inhibition of endogenous polyamine synthesis. Mapping of spermine-binding sites and heparanase, heparin lyase and nitric oxide/nitrite cleavage sites. J. Biol. Chem., 276, 46779-46791.
9. Ding, K., Mani, K., Cheng, F., Belting, M., and Fransson, L.-Å. (2002) Copper-dependent autocleavage of glypican-1 heparan sulfate by nitric oxide derived from intrinsic nitrosothiols. J. Biol. Chem., 277, 33353-33360.
10. Doi, K., Akaike, T., Horie, H., Noguchi, Y., Fujii, S., Beppu, T., Ogawa, M., and Maeda, H. (1996) Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth. Cancer, 77, 1598-1604.
11. Eccles, S. (1999) Heparanase: breaking down barriers in tumours. Nature Med., 5, 735-736.
12. Esko, J.D. and Selleck, S.B. (2002) Order out of chaos: assembly of ligand bindings sites in heparan sulfate. Annu. Rev. Biochem., 71, 435-471.
13. Filmus, J. and Selleck, S.B. (2001) Glypicans: proteoglycans with a surprise. J. Clin. Invest., 108, 497-501.
14. Fransson, L.-Å. (2003) Glypicans. Int. J. Biochem. Cell Biol., 35, 125-129.
15. Goldshmidt, O., Zcharia, E., Aingorn, H., Guatta-Rangini, Z., Atzmon, R., Michal, I., Pecker, I., Mitrani, E., and Vlodavsky, I. (2001) Expression pattern and secretion of human and chicken heparanase are determined by their signal peptide sequence. J. Biol. Chem., 276, 29178-29187.
16. Lehmann, S. (2002) Metal ions and prion diseases. Curr. Opinion Chem. Biol., 6, 187-192.
17. Leteux, C., Chai, W., Nagai, K., Herbert, C.G., Lawson, A.M., and Feizi, T. (2001) 10E4 antigen of scrapie lesions contains an unusual nonsulfated heparan motif. J. Biol. Chem., 276, 12539-12545.
18. Lindegren, H., Östlund, P., Gyllberg, H., and Bedecs, K. (2003) Loss of lipopolysaccharide-induced nitric oxide production and inducible nitric oxide expression in scrapie-infected N2a cells. J. Neurosci. Res., 71, 291-299.
19. Mani, K., Jönsson, M., Edgren, G., Belting, M., and Fransson, L.-Å. (2000) A novel role for nitric oxide in the endogenous degradation of heparan sulphate during recycling of glypican-1 in vascular endothelial cells. Glycobiology, 10, 577-586.
20. Pejler, G., Lindahl, U., Larm, O., Scholander, E., Sandgren, E. and Lundblad, A. (1988) Monoclonal antibodies specific for oligosaccharides prepared by partial nitrous acid deamination of heparin. J. Biol. Chem., 263, 5197-5201.
21. Perrimon, N. and Bernfield, M. (2000) Specificities of heparan sulphate proteoglycans in developmental processes. Nature, 404, 725-728.
22. Sandgren, S. and Belting, M. (2003) Suramin selectively inhibits carcinoma cell growth that is dependent on extracellular polyamines. Anticancer Res., 23, 1223-1228.
23. Thomsen, L.L. and Miles, D.W. (1998) Role of nitric oxide in tumour progression: lessons from human tumours. Cancer Metastasis Rev., 17, 107-118.
24. van den Born, J., Gunnarsson, K., Bakker, M.A.H., Kjellén, L., Kusche-Gullberg, M., Maccarana, M., Berden, J.M.H., and Lindahl, U. (1995) Presence of N-unsubstituted glucosamine units in native heparan sulfate revealed by a monoclonal antibody. J. Biol. Chem., 270, 31303-31309.
25. van Horssen, J., Wesseling, P., van den Heuvel, L.P.W.J., de Waal, R.M.W., and Verbeek, M.M. (2003) Heparan sulfate proteglycans in Alzheimer's disease and amyloid-related disorders. Lancet Neurol., 2, 482-492.
26. Vlodavsky, I., Friedmann, Y., Elkin, M., Aingorn, H., Atzmon, R., Ishai-Mikaeli, R., Bitan, M., Pappo, O., Peretz, T., Michal, I., and others. (1999) Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nature Med., 7, 793-802.
27. Westling, C. and Lindahl, U. (2002) Location of N-unsubstituted glucosamine residues in heparan sulfate. J. Biol. Chem., 277, 49247-49255.